Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immune Mediators and Metabolites to Stratify Systemic Lupus Erythematosus Patients at High Risk of Cardio Vascular Diseases

NCT04276701 is registered in ClinicalTrials.gov with University Hospital, Bordeaux as lead sponsor.

NCT NCT04276701
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04276701 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immune Mediators and Metabolites to Stratify Systemic Lupus Erythematosus Patients at High Risk of Cardio Vascular Diseases
Lead sponsor
University Hospital, Bordeaux
Phase
Not applicable
Overall status
Active, not recruiting
Start date
March 10, 2021
Completion date
March 31, 2027
Enrollment
500 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

systemic lupus erythematosus